Here are five notes:
1. The device has been covered in more than 27 news outlets.
2. The CES Last Gadget Standing competition selected Quell as one of 10 finalists.
3. NeuroMetrix received FDA clearance for its next generation Quell.
4. The new version of Quell allows patients to control their therapy with a mobile app. It will be available in March 2016.
5. “The interest in Quell continues to grow, and there is clearly a need for wearable technology that makes a meaningful and clear difference in people’s lives,” said Shai N. Gozani, MD, PhD, president and CEO of NeuroMetrix.
More articles on devices:
Orthopedic power tools industry report 2016 — 6 quick notes
Medtech revenue up 168%: 5 insights
University of Delaware receives magnet for enhanced imaging of brain: 3 things to know
